Benefits and Harm of Treatment with P2Y12 Inhibitors beyond 12 Months in Patients with Coronary Artery Disease
Mads Lamm Larsen(Aarhus University), Anne‐Mette Hvas(Aarhus University), Erik Lerkevang Grove(Hospital South West Jutland), Steen Dalby Kristensen(Aarhus University)
Cited by 1
Related Papers
Platelet characteristics in patients with essential thrombocytosis
|Cytometry Part B Clinical Cytometry|2018|46
Prognostic Value of Coronary CT Angiography–derived Fractional Flow Reserve on 3-year Outcomes in Patients with Stable Angina
|Radiology|2023|42
Platelet microRNA expression and association with platelet maturity and function in patients with essential thrombocythemia
|Platelets|2019|31